Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1886 | 416 | 0.3822 | 0.3772 | 0.2206 | 0.2307 |
WM-115 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1883 | 435 | 0.3765 | 0.3772 | 0.2310 | 0.2307 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1039 | 854 | 0.0428 | 0.0449 | 0.8219 | 0.8382 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1213 | 1019 | 0.0448 | 0.0449 | 0.8401 | 0.8382 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1385 | 1181 | 0.0471 | 0.0449 | 0.8527 | 0.8382 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1460 | 1042 | 0.0966 | 0.0871 | 0.7137 | 0.7176 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1381 | 996 | 0.0890 | 0.0871 | 0.7212 | 0.7176 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1163 | 835 | 0.0758 | 0.0871 | 0.7180 | 0.7176 |
A-375 | Vemurafenib | Belinostat | 3.160 | 0.000 | uM | 72 | hr | 1 | 2164 | 160 | 0.1530 | 0.1495 | 0.0739 | 0.0897 |
A-375 | Vemurafenib | Belinostat | 3.160 | 0.000 | uM | 72 | hr | 2 | 2130 | 167 | 0.1499 | 0.1495 | 0.0784 | 0.0897 |
A-375 | Vemurafenib | Belinostat | 3.160 | 0.000 | uM | 72 | hr | 3 | 2158 | 252 | 0.1455 | 0.1495 | 0.1168 | 0.0897 |
A-375 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 1 | 1468 | 826 | 0.0490 | 0.0484 | 0.5627 | 0.5323 |
A-375 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 2 | 1407 | 591 | 0.0623 | 0.0484 | 0.4200 | 0.5323 |
A-375 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 3 | 1148 | 705 | 0.0338 | 0.0484 | 0.6141 | 0.5323 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1046 | 239 | 0.0422 | 0.0453 | 0.2285 | 0.2134 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1114 | 238 | 0.0459 | 0.0453 | 0.2136 | 0.2134 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1136 | 225 | 0.0477 | 0.0453 | 0.1981 | 0.2134 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1152 | 244 | 0.0475 | 0.0584 | 0.2118 | 0.2015 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1511 | 288 | 0.0640 | 0.0584 | 0.1906 | 0.2015 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1524 | 308 | 0.0637 | 0.0584 | 0.2021 | 0.2015 |
MZ7-mel | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1318 | 399 | 0.1848 | 0.2350 | 0.3027 | 0.3040 |
MZ7-mel | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1875 | 585 | 0.2594 | 0.2350 | 0.3120 | 0.3040 |
MZ7-mel | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1844 | 548 | 0.2606 | 0.2350 | 0.2972 | 0.3040 |
MZ7-mel | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 776 | 178 | 0.1203 | 0.1382 | 0.2294 | 0.2130 |
MZ7-mel | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 873 | 185 | 0.1384 | 0.1382 | 0.2119 | 0.2130 |